These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23213667)

  • 1. Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement.
    Wkly Epidemiol Rec; 2012 Nov; 87(48):478-82. PubMed ID: 23213667
    [No Abstract]   [Full Text] [Related]  

  • 2. Global Programme to eliminate lymphatic filariasis: progress report on mass drug administration, 2010.
    Wkly Epidemiol Rec; 2011 Aug; 86(35):377-88. PubMed ID: 21887884
    [No Abstract]   [Full Text] [Related]  

  • 3. Global programme to eliminate lymphatic filariasis: progress report, 2011.
    Wkly Epidemiol Rec; 2012 Sep; 87(37):346-56. PubMed ID: 22977953
    [No Abstract]   [Full Text] [Related]  

  • 4. Global programme to eliminate lymphatic filariasis: progress report for 2012.
    Wkly Epidemiol Rec; 2013 Sep; 88(37):389-99. PubMed ID: 24073461
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lymphatic filariasis].
    Sante; 2000; 10(5):360-1. PubMed ID: 11221698
    [No Abstract]   [Full Text] [Related]  

  • 6. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2009 Oct; 84(42):437-44. PubMed ID: 19860021
    [No Abstract]   [Full Text] [Related]  

  • 7. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2010 Sep; 85(38):365-72. PubMed ID: 20853547
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphatic filariasis.
    Wkly Epidemiol Rec; 2003 May; 78(20):171-9. PubMed ID: 12808788
    [No Abstract]   [Full Text] [Related]  

  • 9. Elimination of transmission of lymphatic filariasis in Egypt.
    Molyneux DH
    Lancet; 2006 Mar; 367(9515):966-8. PubMed ID: 16564345
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing morbidity and preventing disability in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement.
    Wkly Epidemiol Rec; 2011 Dec; 86(51-52):581-5. PubMed ID: 22191103
    [No Abstract]   [Full Text] [Related]  

  • 11. The development of albendazole for lymphatic filariasis.
    Horton J
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S33-40. PubMed ID: 19843396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 489 Global programme to eliminate lymphatic filariasis: progress report, 2014.
    Wkly Epidemiol Rec; 2015 Sep; 90(38):489-504. PubMed ID: 26387149
    [No Abstract]   [Full Text] [Related]  

  • 13. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
    Hooper PJ; Bradley MH; Biswas G; Ottesen EA
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic filariasis elimination: progress in global programme development.
    Molyneux DH; Zagaria N
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S15-40. PubMed ID: 12630391
    [No Abstract]   [Full Text] [Related]  

  • 15. Mass drug treatment for lymphatic filariasis and onchocerciasis.
    Molyneux DH; Bradley M; Hoerauf A; Kyelem D; Taylor MJ
    Trends Parasitol; 2003 Nov; 19(11):516-22. PubMed ID: 14580963
    [No Abstract]   [Full Text] [Related]  

  • 16. Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
    Wkly Epidemiol Rec; 2004 Oct; 79(40):358-65. PubMed ID: 15631012
    [No Abstract]   [Full Text] [Related]  

  • 17. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
    Nandha B; Krishnamoorthy K; Jambulingam P
    Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].
    Dorkenoo AM; Sodahlon YK; Bronzan RN; Yakpa K; Sossou E; Ouro-Medeli A; Teko M; Seim A; Mathieu E
    Bull Soc Pathol Exot; 2015 Aug; 108(3):181-7. PubMed ID: 25476256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.
    Gustavsen KM; Bradley MH; Wright AL
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S11-5. PubMed ID: 19843393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
    Burkot TR; Taleo G; Toeaso V; Ichimori K
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S61-9. PubMed ID: 12625919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.